Shares of Zogenix, Inc. (ZGNX) have traded between 33.43 – 56.5. The next earnings date for Nov 14, 2019. Let’s see how its prospects are shaping up.
What does Zogenix, Inc.(ZGNX) do?
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The comp
ZGNX Insider Trading Insight
On 2019-08-22, Farfel Gail M EVP, Chief Development Officer 3,446 shares of ZGNX. That represents a value of 4,891. Not to be outdone, on 2019-08-09, Smith Michael P S – Sale+OE 15,000 shares of ZGNX. These insiders are clearly in the know because they work closely with the company.
The JCOM Consensus Price Target
The mean recommendation of j2 Global, Inc. from top Wall Street analysts is a Moderate Buy. That is based on 2 analysts on the street. Based on 2 analysts offering 12 month price targets for JCOM in the last 3 months. The average price target is $105.00 with a high estimate of $105.00 and a low estimate of $105.00. Last week, 3 articles articles were published on JCOM and 33% Bearish while 67% Bullish.
JCOM Intraday Trading
JCOM is due to report earnings on Oct 31, 2019. In the last year the price has ranged from 65.07 – 94.83. Recently, Rossen Jeremy sold 2,617 shares of JCOM. He is a -$156,654 shareholder in JCOM.
Looking for stocks similar to ZGNX and JCOM?